Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 19, 2006, Pages 5014-5017

  Lee, Jae Yeol ^a   Park, Seong Jun ^b,c   Park, Sung Jun ^a   Lee, Min Joo ^a   Rhim, Hyewhon ^c   Seo, Seon Hee ^c   Kim, Ki Sun ^d  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Korea University   (South Korea)

^c Korea Institute of Science and Technology   (South Korea)

^d Daebul University   (South Korea)

Author keywords

Cancer cell; Cisplatin; Growth inhibition; T type calcium channel blockers

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T TYPE; CISPLATIN; KYS 05040; KYS 05041; KYS 05044; KYS 05064; KYS 05070; KYS 05071; KYS 05074; KYS 05075; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CALCIUM TRANSPORT; CANCER CELL; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL TRANSPORT; GROWTH INHIBITION; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33747334641     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.07.046     Document Type: Article

References (18)

1. Berridge M.J., Lipp P., and Bootman M.D. Nat. Rev. Mol. Cell Biol. 1 (2000) 11
2. Berridge M.J., Bootman M.D., and Roderick H.L. Nat. Rev. Mol. Cell Biol. 4 (2003) 517
3. Whitfield J.F., Boynton A.L., MacManus J.P., Rixon R.H., Sikorska M., Tsang B., Walker P.R., and Swierenga S.H. Ann. NY Acad. Sci. 339 (1980) 216
4. Moolenaar F., Yska J.P., Visser J., and Meijer D.K. Eur. J. Clin. Pharmacol. 29 (1985) 119
5. Whitaker M., and Patel R. Development 108 (1990) 525
6. Lu K.P., and Means A.R. Endocr. Rev. 14 (1993) 40
7. Clapham D.E. Cell 80 (1995) 259
8. Gray L.S., Perez-Reyes E., Gamorra J.C., Haverstick D.M., Shattock M., McLatchie L., Harper J., Brooks G., Heady T., and Macdonald T.L. Cell Calcium 36 (2004) 489
9. McCalmont W.F., Heady T.N., Patterson J.R., Lindenmuth M.A., Haverstick D.M., Gray L.S., and Macdonald T.L. Bioorg. Med. Chem. Lett. 14 (2004) 3691
10. McCalmont W.F., Patterson J.R., Lindenmuth M.A., Heady T.N., Haverstick D.M., Gray L.S., and Macdonald T.L. Bioorg. Med. Chem. 13 (2005) 3821
11. La Vecchia C., and Bosetti C. Eur. J. cancer 39 (2003) 7
12. Monteil A., Chemin J., Bourinet E., Mennessier G., Lory P., and Nargeot J. J. Biol. Chem. 275 (2000) 6090
13. Lee Y.S., Lee B.H., Park S.J., Kang S.B., Rhim H., Park J.-Y., Lee J.-H., Jeong S.-W., and Lee J.Y. Bioorg. Med. Chem. Lett. 14 (2004) 3379
14. Rhim H., Lee Y.S., Park S.J., Chung B.Y., and Lee J.Y. Bioorg. Med. Chem. Lett. 15 (2005) 283
15. Park S.J., Park S.J., Lee M.J., Rhim H., Kim Y., Lee J.-H., Chung B.Y., and Lee J.Y. Bioorg. Med. Chem. 14 (2006) 3502
16. Skehan P., Streng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kenney S., and Boyd M.R. J. Natl. Cancer Inst. 82 (1990) 1107
17. Chang H.-T., Chen W.-C., Chen J.-S., Lu Y.-C., Hsu S.-S., Wang J.-L., Cheng H.-H., Cheng J.-S., Jiann B.-P., Chiang A.-J., Huang J.-K., and Jan C.-R. Life Sci. 76 (2005) 2091
18. Haverstick D.M., Heady T.N., Macdonald T.L., and Gray L.S. Cancer Res. 60 (2000) 1002